Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (ZBH)
NYSE:ZBH
Holding ZBH?
Track your performance easily
ZBH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$100.67 - $133.90
Previous CloseN/A
Volume487.31K
Average Volume (3M)1.56M
Market Cap
$20.85B
Enterprise Value$27.80B
Total Cash (Recent Filing)$634.10M
Total Debt (Recent Filing)$10.63B
Price to Earnings (P/E)20.3
Beta0.71
Next Earnings
Feb 05, 2025EPS Estimate
2.3Last Dividend Ex-Date
Dec 30, 2024Dividend Yield0.92%
Share Statistics
EPS (TTM)5.25
Shares Outstanding199,073,720
10 Day Avg. Volume1,669,952
30 Day Avg. Volume1,557,112
Standard Deviation0.08
R-Squared0.47
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.79
Price to Cash Flow (P/CF)13.40
P/FCF Ratio18.50
Enterprise Value/Market Cap1.33
Enterprise Value/Revenue3.66
Enterprise Value/Gross Profit5.24
Enterprise Value/Ebitda15.38
Forecast
1Y Price Target
$122.23Price Target Upside12.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Zimmer Biomet Holdings News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThere is potential for share price expansion as the company moves from an 11.5-12.0x earnings multiple toward a 14.0-15.0x multiple.
Market PositionOxford Cementless Partial will be the only PMA product in the partial cementless Knee category in the US, providing a unique market position.
Product InnovationZimmer Biomet received FDA PMA approval for its Oxford Cementless Partial Knee System, giving it a competitive advantage in the US market.
Bears Say
Financial GuidanceManagement lowered its 2024 revenue and EPS guidance due to ERP implementation challenges.
Market CompetitionRobotic competition in large joints from companies like JNJ and GMED could impact ZBH's market position.
Market Share LossZBH lost approximately 60 basis points of recon market share, 50 basis points of knee market share, and 80 basis points of hip market share on a global year-over-year basis.
---
Ownership Overview
0.08% Insiders
36.26% Mutual Funds
0.69% Other Institutional Investors
36.64% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ZBH FAQ
What was Zimmer Biomet Holdings’s price range in the past 12 months?
Zimmer Biomet Holdings lowest stock price was $100.67 and its highest was $133.90 in the past 12 months.
What is Zimmer Biomet Holdings’s market cap?
Zimmer Biomet Holdings’s market cap is $20.85B.
When is Zimmer Biomet Holdings’s upcoming earnings report date?
Zimmer Biomet Holdings’s upcoming earnings report date is Feb 05, 2025 which is in 18 days.
How were Zimmer Biomet Holdings’s earnings last quarter?
Zimmer Biomet Holdings released its earnings results on Oct 30, 2024. The company reported $1.74 earnings per share for the quarter, missing the consensus estimate of $1.744 by -$0.004.
Is Zimmer Biomet Holdings overvalued?
According to Wall Street analysts Zimmer Biomet Holdings’s price is currently Undervalued.
Does Zimmer Biomet Holdings pay dividends?
Zimmer Biomet Holdings pays a Quarterly dividend of $0.956 which represents an annual dividend yield of 0.92%. See more information on Zimmer Biomet Holdings dividends here
What is Zimmer Biomet Holdings’s EPS estimate?
Zimmer Biomet Holdings’s EPS estimate is 2.3.
How many shares outstanding does Zimmer Biomet Holdings have?
Zimmer Biomet Holdings has 199,073,720 shares outstanding.
What happened to Zimmer Biomet Holdings’s price movement after its last earnings report?
Zimmer Biomet Holdings reported an EPS of $1.74 in its last earnings report, missing expectations of $1.744. Following the earnings report the stock price went up 5.702%.
Which hedge fund is a major shareholder of Zimmer Biomet Holdings?
Among the largest hedge funds holding Zimmer Biomet Holdings’s share is Dodge & Cox. It holds Zimmer Biomet Holdings’s shares valued at 2B.
---
Zimmer Biomet Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$122.23 (12.20% Upside)
$122.23 (12.20% Upside)
Blogger Sentiment
Bullish
ZBH Sentiment 85%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 716.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days >0.1%
Last 30 Days ▲ 2.2%
Last 30 Days ▲ 2.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.40%
12-Months-Change
Fundamentals
Return on Equity
8.71%
Trailing 12-Months
Asset Growth
2.37%
Trailing 12-Months
Company Description
Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company engages in designing, manufacturing and marketing orthopedic reconstructive products; biologics, sports medicine, extremities and trauma products; spine, dental implants, bone healing, craniomaxillofacial and thoracic products; and related surgical products.
---
ZBH Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mix of positive and negative developments. While Zimmer Biomet demonstrated strong sales growth, product innovation, and improved pricing, challenges such as ERP implementation issues and a decline in the 'Other' category led to a lowered forecast. The resolution of ERP issues and a strong product pipeline suggest potential for future growth, but current hurdles present a balanced outlook.Read More>---
ZBH Net sales Breakdown
62.54% Americas
21.54% EMEA
15.93% APAC
---
ZBH Stock 12 Month Forecast
Average Price Target
$122.23
▲(12.20% Upside)
Technical Analysis
Smith & Nephew Snats
―
Stryker
―
Medtronic
―
Boston Scientific
―
Edwards Lifesciences
―
Intuitive Surgical
―
Best Analysts Covering ZBH
1 Year
1 Year Success Rate
30/45 ratings generated profit
1 Year Average Return
+5.51%
assigned a buy rating 3 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +5.51% per trade.
---